Alpha Tau Medical Ltd carries a market capitalization of 1.18B, placing it among publicly traded companies globally. Its enterprise value stands at 572.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.18B |
| Enterprise Value | 572.14M |
Alpha Tau Medical Ltd currently has 90.18M shares outstanding.
| Shares Outstanding | 90.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -2.98 |
| P/TBV Ratio | 9.14 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Alpha Tau Medical Ltd maintains a current ratio of 7.79, meaning it holds 7.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.79 |
| Quick Ratio | 7.42 |
| Debt / Equity | 20.68 |
| Debt / EBITDA | -0.31 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -59.96 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 11,000.00 |
| Effective Tax Rate | N/A |
Alpha Tau Medical Ltd's stock has gained approximately 332.22591% over the past 52 weeks. The 50-day moving average sits at 10.96, while the 200-day moving average is 7.24.
| Beta (5Y) | N/A |
| 52-Week Price Change | 332.22591% |
| 50-Day Moving Average | 10.96 |
| 200-Day Moving Average | 7.24 |
| Average Volume (20 Days) | N/A |
EBITDA reached -46.29M, while operating income came in at -46.29M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -46.29M |
| Pretax Income | -56.86M |
| Net Income | -56.87M |
| EBITDA | -46.29M |
| EBIT | -46.29M |
| Earnings Per Share (EPS) | -0.63 |
Alpha Tau Medical Ltd holds 76.42M in cash and equivalents against 14.34M in total debt, resulting in a net debt position of 1.77M. Total book value stands at -213.07M, with working capital of 70.90M providing operational flexibility.
| Cash & Cash Equivalents | 76.42M |
| Total Debt | 14.34M |
| Net Debt | 1.77M |
| Equity (Book Value) | -213.07M |
| Book Value Per Share | -2.38 |
| Working Capital | 70.90M |
Alpha Tau Medical Ltd posts an Altman Z-Score of 6.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.29 |